Published in J Gastroenterol on December 08, 2006
Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation. World J Gastroenterol (2012) 1.04
Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: evaluation by transabdominal ultrasonography. J Gastroenterol (2008) 0.87
Effect of domperidone therapy on nocturnal dyspeptic symptoms of functional dyspepsia patients. World J Gastroenterol (2010) 0.80
Acupuncture for Functional Dyspepsia: A Single Blinded, Randomized, Controlled Trial. Evid Based Complement Alternat Med (2015) 0.80
Tibetan herbal formula Padma Digestin modulates gastrointestinal motility in vitro. World J Gastrointest Pharmacol Ther (2013) 0.79
Electro-acupuncture with different current intensities to treat functional constipation: a study protocol for a randomized controlled trial. Trials (2013) 0.78
Can mosapride citrate reduce the volume of lavage solution for colonoscopy preparation? World J Gastroenterol (2013) 0.78
The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage. J Gastroenterol (2009) 0.77
Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial. J Res Med Sci (2015) 0.77
Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia. Adv Biomed Res (2016) 0.75
The Pharmacological Effects of Benachio-F(®) on Rat Gastrointestinal Functions. Biomol Ther (Seoul) (2015) 0.75
Mangiferin, a natural xanthone, accelerates gastrointestinal transit in mice involving cholinergic mechanism. World J Gastroenterol (2012) 0.75
Simotang enhances gastrointestinal motility, motilin and cholecystokinin expression in chronically stressed mice. World J Gastroenterol (2011) 0.75
Electroacupuncture for Functional Constipation: A Multicenter, Randomized, Control Trial. Evid Based Complement Alternat Med (2017) 0.75
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
Functional gastroduodenal disorders. Gastroenterology (2006) 8.51
Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology (1998) 5.34
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology (2000) 4.27
Functional gastroduodenal disorders. Gut (1999) 3.74
Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 3.28
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med (2006) 2.94
Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther (1998) 2.45
American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology (2005) 2.39
Guidelines for the management of dyspepsia. Am J Gastroenterol (2005) 2.39
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Pathophysiology and treatment of functional dyspepsia. Gastroenterology (2004) 2.09
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol (2003) 2.04
Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology (1999) 2.00
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 1.88
Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut (2005) 1.82
Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology (2005) 1.79
Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. Lancet Oncol (2005) 1.77
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med (2004) 1.72
Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology (2004) 1.66
Acupuncture for functional gastrointestinal disorders. J Gastroenterol (2006) 1.66
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology (2001) 1.64
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63
Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis (2001) 1.63
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol (2001) 1.62
Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol (2003) 1.59
Central vagal stimulation evokes gastric volume changes in mice: a novel technique using a miniaturized barostat. Neurogastroenterol Motil (2004) 1.58
Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut (2004) 1.58
Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut (1998) 1.54
Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol (2000) 1.54
Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology (2002) 1.50
Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther (1993) 1.49
Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 1.47
Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut (2003) 1.44
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol (1989) 1.38
Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut (2000) 1.34
Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology (2006) 1.33
The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol (2000) 1.32
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther (2004) 1.32
Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci (1998) 1.31
The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol (2002) 1.31
Abnormalities of the electrogastrogram in functional gastrointestinal disorders. Am J Gastroenterol (1999) 1.31
Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl (1996) 1.29
Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology (2002) 1.28
Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology (1996) 1.28
Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol (1995) 1.27
Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol (1999) 1.27
Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol (2004) 1.27
Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol (2005) 1.24
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol (2001) 1.23
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Nitrergic regulation of colonic transit in rats. Am J Physiol (1999) 1.21
Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol (2006) 1.21
Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut (2001) 1.20
Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut (1995) 1.20
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther (2000) 1.15
First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther (1998) 1.15
Gastroparesis: clinical update. Am J Gastroenterol (2006) 1.15
Central serotonergic and noradrenergic receptors in functional dyspepsia. World J Gastroenterol (2006) 1.13
Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil (2005) 1.13
Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.12
Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol (2006) 1.11
Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol (1997) 1.10
Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther (1997) 1.09
In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br J Pharmacol (2001) 1.09
Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res (1999) 1.08
Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety. J Clin Gastroenterol (2004) 1.06
Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol (2003) 1.04
Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther (2003) 1.04
Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med (2000) 1.03
Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med (1993) 1.02
Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol (2005) 1.00
Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment Pharmacol Ther (2002) 1.00
Impaired nitrergic innervation in rat colitis induced by dextran sulfate sodium. Gastroenterology (2000) 0.99
A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther (2001) 0.99
Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol (2004) 0.98
Acid challenge delays gastric pressure adaptation, blocks gastric emptying and stimulates gastric fluid secretion in the rat. Neurogastroenterol Motil (2003) 0.98
New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Aliment Pharmacol Ther (2005) 0.97
Influence of tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment Pharmacol Ther (2003) 0.96
Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol (2001) 0.96
Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol (2004) 0.95
Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia. Dig Dis Sci (2000) 0.94
Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut (2002) 0.93
H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther (2001) 0.93
Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci (2003) 0.93
Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms. Am J Gastroenterol (2003) 0.93
Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther (1996) 0.92
Effects of itopride hydrochloride on plasma gut-regulatory peptide and stress-related hormone levels in healthy human subjects. Pharmacology (2006) 0.92
Intragastric distribution of a standardized meal in health and functional dyspepsia: correlation with specific symptoms. Neurogastroenterol Motil (2003) 0.92
Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia. J Clin Gastroenterol (2007) 0.92
Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome. Neurogastroenterol Motil (2003) 0.92
Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol (2005) 0.92
Prokinetic effect of a Kampo medicine, Hange-koboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine (2005) 0.91
Vagally-regulated gastric motor activity: evidence for kainate and NMDA receptor mediation. Eur J Pharmacol (1999) 0.90
Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis (2006) 0.90
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med (2002) 2.40
The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell Microbiol (2003) 2.20
Long-term survival in three patients with metastatic non-small cell lung cancer treated with gefitinib. Lung Cancer (2006) 2.08
Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis (2005) 2.04
Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion (2009) 2.01
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut (2007) 1.99
WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility. EMBO J (2003) 1.98
Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc (2011) 1.94
Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med (2004) 1.91
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology (2008) 1.87
JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem (2009) 1.82
Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol (2004) 1.82
The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med (2007) 1.81
Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care (2010) 1.81
Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res (2005) 1.80
Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest (2010) 1.76
Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol (2002) 1.70
Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.70
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma. J Gastroenterol Hepatol (2004) 1.57
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol (2010) 1.56
Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration (2005) 1.55
CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am J Physiol Gastrointest Liver Physiol (2010) 1.54
High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol (2007) 1.54
Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection. Int J Antimicrob Agents (2009) 1.52
An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia. Respiration (2002) 1.51
Inducible clustering of membrane-targeted SH3 domains of the adaptor protein Nck triggers localized actin polymerization. Curr Biol (2004) 1.50
Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis. Intern Med (2005) 1.48
Mutational analysis of the beta-tubulin gene in lung cancer. Lung Cancer (2002) 1.48
Direct hemoperfusion using immobilized polymyxin B in patients with rapidly progressive interstitial pneumonias: a retrospective study. Respiration (2010) 1.48
Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy. J Gastroenterol (2006) 1.48
TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology (2008) 1.45
MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer (2010) 1.44
Takayasu arteritis developing during treatment of ulcerative colitis with infliximab. Mod Rheumatol (2012) 1.44
Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol (2005) 1.43
Preventive effects of parathyroid hormone-related peptide on stress-induced gastric hypercontraction in the rat. J Gastroenterol Hepatol (2002) 1.43
Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis. Intern Med (2005) 1.41
Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol (2011) 1.41
A small outbreak of pulmonary tuberculosis in non-close contact patrons of a bar. Intern Med (2004) 1.39
A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin. Intern Med (2012) 1.38
Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest (2009) 1.37
MicroRNAs and esophageal squamous cell carcinoma. Digestion (2010) 1.35
Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol (2003) 1.34
A case of asymptomatic fusiform aneurysm of the superior vena cava detected by magnetic resonance imaging. Int J Cardiol (2006) 1.29
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance. Cancer Res (2005) 1.28
Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol (2003) 1.27
Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol (2009) 1.27
Development of a reverse transcription-loop-mediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource-limited settings. J Clin Microbiol (2010) 1.26
The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. Hepatology (2010) 1.25
Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. Lung Cancer (2005) 1.24
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J Transl Med (2011) 1.22
Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J (2008) 1.20
The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) (2012) 1.20
High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med (2003) 1.19
Peroral endoscopic myotomy for esophageal achalasia: clinical impact of 28 cases. Dig Endosc (2013) 1.19
Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem (2008) 1.17
Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob Agents Chemother (2002) 1.17
ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis (2009) 1.17
Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer. Cancer Lett (2003) 1.15
Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res (2003) 1.15
Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002). Diagn Microbiol Infect Dis (2004) 1.15
Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol (2005) 1.14
Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines. Gastroenterology (2009) 1.14
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol (2010) 1.13
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion (2008) 1.13
The Japanese Respiratory Society guidelines for management of cough. Respirology (2006) 1.13
Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob Agents Chemother (2005) 1.12
Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother (2006) 1.11
Rapid screening of topoisomerase gene mutations by a novel melting curve analysis method for early warning of fluoroquinolone-resistant Streptococcus pneumoniae emergence. J Clin Microbiol (2006) 1.11
Clinical outcomes of endoscopic submucosal dissection in elderly patients with early gastric cancer. Eur J Gastroenterol Hepatol (2010) 1.11